Program

2nd SFCNS Summer School 2018Modul II• Sleep and epilepsy• Emergencies in the Neurocenter

Co-Presidents of the organizing committeeProf. Marcel Arnold, MD, BernRebekka Kurmann, MD, Bern

24-25 August 2018Inselspital, Bern / Switzerland

www.sfcns-summerschool-2018.congress-imk.ch

Org

aniz

ed b

y IM

K In

stitu

te fo

r med

icin

e an

d co

mm

unic

atio

n Lt

d

Dear colleagues,

It is our great pleasure, on behalf of the co-presidents of the organizing committee, Prof. Marcel Arnold and Dr. Rebekka Kurmann and the president of the Swiss Federation of Clinical Neuro-Societies (SFCNS), Prof. Karl Schaller, to cordially invite you to the SFCNS Summer School 2018. The event will take place from August 24-25, 2018 at the Inselspital in Bern.

The SFCNS was founded 2009 to promote collaborations and interactions between clinical neurosoci-eties in Switzerland in order to enhance knowledge, information, and overall impact of our disciplines at scientific, public and political level.

The SFCNS Summer School is mainly aimed at neurologists, neuroradiologists, neurosurgeons, neuropediatrics, psychiatrist and other neuroscientists. Module I took place for the first time in 2017 and will be pursued by Module II and Module III in 2018 and 2019 respectively.

The Module II is constructed around the following topics:• Sleep • Epilepsy• Emergencies in the Neurocenter

We hope that this event will be of interest to you and we look very much forward to welcoming you in Bern.

Welcome to Bern

Partner companies 2018

Prof. Marcel Arnold, MDCo-President of the organizing committee

Rebekka Kurmann, MDCo-President of the organizing committee

Prof. Karl Schaller, MD President SFCNS

Program | Friday, August 24, 2018 - Sleep and Epilepsy

SleepChairs: Johannes Mathis, Bern; Corrado Garbazza, Basel

09:15- 09:40 Chronobiology of sleep Corrado Garbazza, Basel/Lugano

09:40-10:05 How will we sleep in the future? Ramin Khatami, Barmelweid

10:05-10:40 Coffee break

10:40-11:05 New aspects in RLSJohannes Mathis, Bern

11:05-11:30 Sleep and sleep disorders in childhood Alexandre Datta, Basel

11:30-12:00 Differentiation of nocturnal seizures and parasomniaLino Nobili, Milan, IT

12:00-13:00 Lunchsponsored by

EpilepsyChairs: Frédéric Zubler, Bern; Bigna Bölsterli, Zurich

13:00-13:20 Epilepsy in women Barbara Tettenborn, St. Gallen

13:20-13:50 Treatment and prognosis of status epilepticus Vincent Alvarez, Sion

13:50-14:20 Principles of modern pharmacotherapy in epilepsy Martinus Hauf, Tschugg

14:20-14:40 Epilepsy in childhood: genetic, structural or metabolic? Sarah E. Bürki, Bern

14:40-15:10 Case/Videoforum: Is it epileptic or not? Matteo Caporro, Bern

15:10-15:40 Coffee break

15:40-16:00 Lateralising value of neuropsychological assessment in epilepsy Céline Gobbo, Geneva

16:00-16:30 Modern epilepsy surgery: the neurologists view (the origin of seizures in structural epilepsy) Kaspar Schindler, Bern

16:30-17:00 Modern epilepsy surgery: the neuroradiologists view Roland Wiest, Bern

17:00-17:30 Modern epilepsy surgery: the neurosurgeons view Claudio Pollo, Bern

19:00 Networking Event at Restaurant Marzilibrücke

Program | Saturday, August 25, 2018 - Emergencies in the Neurocenter

Emergencies in the Neurocenter IChairs: Marie-Luise Mono, Zurich; Philipp Balcerak, St. Gallen

09:15- 09:40 Top ten disorders in the neuro emergency roomMarie-Luise Mono, Zurich

09:40-10:05 Modern multidisciplinary stroke management Marcel Arnold, Bern

10:05-10:30 Acute loss of consciousness- what to do next?Georg Kägi, St. Gallen

10:30-11:00 Coffee break

11:00-11:25 Neuropediatric emergencies Maja Steinlin, Bern

11:25-11:50 Movement disorders in the emergency room (video demonstration and Quiz) Stephan Bohlhalter, Luzern

11:50-12:15 Pearls in the neuroemergency room: case presentations Thomas Horvath, Bern

12:15-13:30 Lunchsponsored by

Emergencies in the Neurocenter IIChairs: Christian Fung, Freiburg, DE; Irena Zubak, Bern

13:30-13:55 Emergencies of the spinal cord Karl Kotbauer, Luzern

13:55-14:20 Traumatic brain injuryChristian Zweifel, Chur

14:20-15:45 The role of the neurosurgeon in intracranial hemorrhageChristian Fung, Bern

14:45-15:15 Coffee break

15:15-15:40 Diagnosis and treatment of compressive radicular and spinal cord syndromes Menno Germans, Zurich

15:40-16:05 Multidisciplinary management of cerebral aneurysms: the neurosurgeon’s view Philippe Bijlenga, Geneva

16:05-17:00 Multidisciplinary management of cerebral aneurysms: the neuroradiologist’s view Luca Remonda, Aarau

Schutz

Xarelto® – Erfahrung und Vertrauen7

Leben*1–6

fürs echte

Referenzen: 1. Patel et al. Rivaroxaban versus warfarin in nonvalvular atrial fi brillation. N Engl J Med 2011; 365:883–91. 2. Camm et al. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fi brilation. Eur Heart J. 2016 Apr 7;37(14):1145-53. 3. Prins et al. Oral Rivaroxaban versus Standard Therapy for the Treatment of Symptomatic Venous Thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis Journal 2013;11:21. 4. Ageno et al. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Lancet Haematol. 2016 Jan;3(1):e12–21. 5. Turpie et al.: Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Thromb Haemost. 2011;105(3):444–453. 6. Turpie et al.: A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment. Thromb Haemost. 2014;111(1):94–102. 7. IMS Health MIDAS, Database: Monthly Sales February 2018.Gekürzte Fachinformation Xarelto® (Rivaroxaban): Direkter Faktor Xa-Inhibitor Z: Filmtabl. zu 10, 15 und 20mg Rivaroxaban I: a) Thromboseprophylaxe bei grösseren orthopädischen Eingriffen a. d. unteren Extremitäten wie Hüft- und Knieprothesen. b) Behandlung von Lungenembolie (LE) und tiefer Venenthrombose (TVT) sowie Prophylaxe rezidivieren-der TVT und LE. c) Schlaganfallprophylaxe und Prophylaxe system. Embolien bei nicht-valvulärem Vorhoffl immern. D: a)1x/Tag 10mg. b)2x/Tag 15mg für die ersten 21 Tage, gefolgt von 20mg 1x/Tag c)1x/Tag 20mg; bei Krea-Cl 15-49ml/min: 1x/Tag 15mg. 15mg und 20mg mit Mahlzeit einnehmen. KI: Überempfi ndlichkeit auf Inhaltsstoffe, akute bakt. Endokarditis, klin. sign. aktive Blutungen, schw. Lebererkrankung/ Leberinsuffi zienz (LI) mit relev. erhöhtem Blutungsrisiko; leichte LI in Komb. mit Koagulopathie, dialysepfl . Niereninsuffi zienz (NI), akute gastrointestinale (GI) Ulzera oder GI ulzerative Erkrankungen, Schwangerschaft, Stillzeit. W: Komedikation (siehe «IA»); <18 Jahre; künstl. Herzklappen; d. Hämostase beeinfl . Arzneimittel. VM: NI (Krea-Cl 15-29ml/min) od. NI in Komb. mit Arzneimittel, die den Xarelto®-Plasmaspiegel erhöhen, erhöhtes Risiko unkontrollierter Blutungen und hämorrhag. Diathese, kurz zurück-liegender hämorrhag. Schlaganfall, intrakran. o. intrazerebr. Hämorrhagie, kürzlich aufgetretene GI Ulzera/ulzerative Erkrankungen, schwere unkontrollierte Hypertonie, vask. Retinopathie, intraspinale o. intrazerebr. Gefässanomalien, kurz zurückliegende Hirn-, Spinal-, Augen-OP, Bronchiektasie oder pulmonale Blutung in der Anamnese, Spinalanästhesie und -punktion, mind. 24 Stunden vor invasiven Verfahren/ chirurgischen Eingriffen absetzen, gleichzeitige Gabe von d. Hämostase beeinfl . Arzneimitteln. Einzelfälle von Agranulozytose und SJS wurden berich-tet. Häufi ge UAW: Blutungen, Anämie, Schwindel, Kopfschmerz, Augenblutungen, Hämatome, Epistaxis, Hämoptysis, Nausea, Obstipation, Durchfall, Leberenzymerhöhungen (ASAT, ALAT), Pruritus, Rash, Schmerzen i. d. Extrem., Fieber, periph. Ödem, Asthenie. IA: Starke CYP 3A4 + P-gp -Inhib. (Ritonavir, Ketoconazol), starke CYP 3A4 + P-gp -Induk. (Rifampicin, Carbamazepin, Phenobarbital, Johanniskraut), d. Hämostase beeinfl . Arzneimittel. Packg.: 10mg à 10 und 30; 15mg und 20mg à je 14, 28 o. 98 Filmtabl.; jew. Spitalpackung 10x1 Film-tabl. (B), kassenzulässig. Für weitere Informationen siehe www.swissmedicinfo.ch. Vertrieb: Bayer (Schweiz) AG, Grubenstr. 6, 8045 Zürich. L.CH.MKT.HC.02.2017.1074-DE/FR/IT L.CH

.MKT

.HC.

03.2

018.

1258

-DE/

FR/IT

* Prospektive Real-Life-Studien («echtes Leben») bestätigen das in den jeweiligen Phase-III-Studien gezeigte positive Nutzen-Risiko-Profil in den zugelassenen Indikationen.

Xarelto_Inserat_2018_145x210_mitBeschnitt_dt.indd 1 04.04.18 14:02

SSNS SNS SSR ASNP/SVNP

24.08.2018 8 8 6 6

25.08.2018 8 8 6 5

Friday and Saturday, August 24-25, 2018

InselspitalPathologisches Institut, Hörsaal 7 (Auditorium Langhans), Eingang 43Murtenstrasse 31, CH-3010 Bern, www.insel.ch

Prof. Marcel Arnold, MD, Bern; Co-President Rebekka Kurmann, MD, Bern; Co-President

The official congress language is English.

IMK Institute for medicine and communication LtdMünsterberg 1, CH-4001 Basel, congress@imk.ch, www.imk.chPhone +41 61 271 35 51 | Fax +41 61 271 33 38

Online via the congress website: sfcns-summerschool-2018.congress-imk.ch

*Members of the following societies may register in the category members: YouCliN, SNS/SAYN, SSNS/SYNS, SSNC, SSNP, SSNR, SSNPath, SSBP, SHS, SLAE, SSNRehab, SANP, SSBN, SSS, Aphasie Suisse

IMK must be informed about cancellations in written form until July 15, 2018. We will be able to reimburse 50% of the congress fees. After July 15, 2018 no refunds will be made.

Friday, August 24, 2018, 19:00, Restaurant Marzilibrücke, Bern

Date

Congress venue

Organizing committee

Language

Professional Congress Organizer (PCO)

Registration

Registration fees(in CHF)

Cancellation policy

Networking Event

Credits

Day Ticket 2-Day-Pass Networking Dinner

Members* 100.- 200.- 50.-

Non members 150.- 300.- 50.-

Students 100.- 50.-

General Information

EACCME: Credits requested

• Philippe Balcerak, MD, St. Gallen• Rike Barth, MD, Bern• Prof. Claudio Bassetti, MD, Bern• PD Gian Marco De Marchis, MD, Basel• Olivia Geisseler, PhD• PD Barbara Goeggel-Simonetti, MD, Bellinzona

• PD Mira Katan, MD, Zurich• Prof. Mauro Manconi, MD, Lugano• Prof. Luca Remonda, MD, Aarau

• Prof. Karl Schaller, MD, Geneva• Prof. Kaspar Schindler, MD, PhD, Bern• David Schreier, MD, Bern• Arseny Sokolov, MD, Lausanne• Prof. Maja Steinlin, MD, Bern• Martin Stienen, MD, Zurich• Martin Welter, MD, Thun• Prof. Roland Wiest, MD, Bern• PD Sebastian Winklhofer, MD, Zurich

The Swiss Federation of Clinical Neuro-Societies (SFCNS) was officially founded in 2009. First steps in that direction were taken at the Joint Meeting of six Clinical Neuroscience Societies in April 2008 in Montreux, which commemorated the centenary of the Swiss Neurological Society. The six founding societies decided to close ranks and form a Swiss Federation of Clinical Neuro-Societies (SFCNS) which marked the beginning of a new cooperative effort to strengthen the clinical neuro-sciences in Switzerland. The federation should formalise and structure the joint medico-political, educational and clinical research efforts. Its further aim is to hold common meetings on a regular basis to facilitate mutual interactions and be open also to other medical groups pursuing clinical neuroscience interests.

Ordinary members SFCNS Swiss Neurological Society SNS | www.swissneuro.chSwiss Society of Neurosurgery SSNS | www.swissneurosurgery.chSwiss Society of Clinical Neurophysiology SSCN | www.sgkn.chSwiss Society of Neuropaediatrics SSNP | www.neuropaediatrie.chSwiss Society of Neuroradiology SSNR | www.swissneuroradiology.chSwiss Society of Neuropathology SSNPath | www.ssn.uzh.chSwiss Society of Biological Psychiatry SSBP | www.ssbp.ch

Associated membersSwiss Headache Society SHS | www.headache.chSwiss Society for Neurorehabilitation SSNRehabSwiss Association of Neuropsychology | www.neuropsy.chSwiss Society of Behavioural Neurology SSBN | www.sgvn.chSwiss Stroke Society SSS | www.neurovasc.ch

Extraordinary membersSwiss League Against Epilepsy SLaE | www.epi.chaphasie suisse | www.aphasie.ch

Portrait SFCNS

www.sfcns.ch

The Young Clinical Neuroscientists (YouCliN) Network within the SFCNS brings together juniors accross all clinical neuroscience disciplines united within the SFCNS.

Please follow us on Facebook www.facebook.com/youclin.sfcns.5

Twitter www.twitter.com/SFCNSyouclin

Swiss Federation of Clinical Neuro-Societies

sfcns2019.congress-imk.ch

4th SFCNS Congress

First Announcement

October 23 - 25, 2019SwissTech Convention Center, EPFLLausanne

Org

aniz

ed b

y IM

K In

stitu

te fo

r med

icin

e an

d co

mm

unic

atio

n Lt

d©

Sw

issT

ech

Conv

entio

n Ce

nter